Pneumococcal Carriage in Patients With Lower Respiratory Tract Infection (LRTI)
A Study of Pneumococcal Carriage in Hospitalised Patients With Lower Respiratory Tract Infections
1 other identifier
observational
38
1 country
1
Brief Summary
We are interested in developing new and better ways of diagnosing the cause of lower respiratory tract infections including pneumonia. Currently we find the causal bug (bacteria or virus) in less than 50% of patients with pneumonia. A potential way to better find the bug responsible may include checking for bugs in the nose by a nasal wash or swab. Better diagnostics would allow more targeted antibiotic therapy and in the future this technique may be used as a way of checking the efficiency of new vaccines. We are recruiting both patients with respiratory infections and also a 'control' group of patients admitted to hospital who do not have respiratory infection. We need to have access to your medical history information to make sure you are eligible and suitable for the study. If you participate in the study, it is important that the study doctors continue to have access to your personal Investigator Designation Contact telephone Dr Andrea Collins PhD student/research SpR xxxxxxxxxxxxx Carole Hancock Research nurse 0151 706 4856 Prof Stephen Gordon Principle Investigator 0151 705 3169 NW PIL V1.3: October 2012 REC ref: 12/NW/0713 information so you can be followed up properly and so we can contact you during the study if needed. Patients in both groups will have a nasal wash (or swab), blood (30mls = 6 teaspoons) and urine taken on the day of recruitment and a nasal wash (or swab) and blood (30mls = 6 teaspoons) taken 6 weeks later (this is likely to be as an out-patient at the Royal Liverpool, in extreme circumstances this will occur at the patient's home).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedFirst Submitted
Initial submission to the registry
May 21, 2013
CompletedFirst Posted
Study publicly available on registry
May 23, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2014
CompletedJune 9, 2022
May 1, 2013
1 year
May 21, 2013
June 6, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of pneumococcal carriage in patients hospitalised with LRTI and age matched controls.
Pneumococcal colonisation will be defined based on the culture (+/-PCR) result of nasal wash/NPS taken at day 0 and 6 weeks.
6weeks
Secondary Outcomes (1)
Density of pneumococcal carriage in patients hospitalised with LRTI and age matched controls
6weeks
Study Arms (2)
LRTI group
Non-pneumonic LRTI (no radiological consolidation but the presence of clinical signs) or community acquired pneumonia (radiological consolidation) Able to give fully informed consent (mental capacity assessed using trust guidelines) Age\>18yrs old Fluent English speaker
Control group
Able to give fully informed consent (mental capacity assessed using trust guidelines) Age\>18yrs old Fluent English speaker
Eligibility Criteria
Patients admitted to the hospital with Lower Respiratory Tract Infection
You may qualify if:
- Non-pneumonic LRTI (no radiological consolidation but the presence of clinical signs) or community acquired pneumonia (radiological consolidation) Able to give fully informed consent (mental capacity assessed using trust guidelines) Age\>18yrs old Fluent English speaker
You may not qualify if:
- Infective exacerbation of COPD or bronchiectasis without consolidation Oxygen saturations \<86% on air Tuberculosis suspected Neutropenia
- Able to give fully informed consent (mental capacity assessed using trust guidelines) Age\>18yrs old
- years of recruited LRTI patient Fluent English speaker
- Signs/symptoms of respiratory infection Oxygen saturations \<86% on air Neutropenia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Royal Liverpool University Hospital
Liverpool, L7 8XP, United Kingdom
Related Publications (1)
German EL, Al-Hakim B, Mitsi E, Pennington SH, Gritzfeld JF, Hyder-Wright AD, Banyard A, Gordon SB, Collins AM, Ferreira DM. Anti-protein immunoglobulin M responses to pneumococcus are not associated with aging. Pneumonia (Nathan). 2018 Jun 5;10:5. doi: 10.1186/s41479-018-0048-3. eCollection 2018.
PMID: 29992080DERIVED
Biospecimen
Blood samples Nasal wash samples Nasopharyngeal swabs (where nasal wash not possible) Urine samples
Study Officials
- PRINCIPAL INVESTIGATOR
Professor Stephen Gordon
Royal Liverpool University Hospital/ Liverpool School of Tropical Medicine
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 21, 2013
First Posted
May 23, 2013
Study Start
January 1, 2013
Primary Completion
January 1, 2014
Study Completion
November 1, 2014
Last Updated
June 9, 2022
Record last verified: 2013-05